Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death
Published: March 28, 2016
- Wearable cardioverter defibrillators (WCDs) have emerged as a bridge to permanent device implantation in certain patients at risk for sudden cardiac death (SCD).
- Though the use of WCDs has been increasing, there has been continued uncertainty regarding appropriate indications for this therapy.
- This advisory aims to provide comprehensive review, assessment, and guidance regarding WCD therapy in contemporary clinical practice.